Old Well Partners, LLC Nuvalent, Inc. Transaction History

Old Well Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Aug 19, 2024	SELL	$42.42 - $80.28 $72,114 - $136,476	-1,700 Reduced 29.31%	4,100 $301,000
Q4 2023 Feb 14, 2024	SELL	$42.42 - $80.28 $72,114 - $136,476	-1,700 Reduced 29.31%	4,100 $301,000
Q3 2023 Aug 19, 2024	BUY	$39.12 - $49.85 $226,895 - $289,130	5,800 New	5,800 $266,000
Q2 2023 Aug 14, 2023	BUY	$23.58 - $44.68 $136,764 - $259,144	5,800 New	5,800 $244,000
Q2 2022 Aug 15, 2022	BUY	$7.4 - $15.07 $78,440 - $159,742	10,600 New	10,600 $144,000

210

59.5M

450K

619K

Ticker NUVL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,977,800
Market Cap $3.92B
Description
Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...

Get notified when there are updates to the investment portfolio of Old Well Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Old Well Partners, LLC with notifications on news.